HISTOLOGY AND HISTOPATHOLOGY

Cellular and Molecular Biology

The immunohistochemical expression of metallothionein in inflammatory bowel disease. Correlation with HLA-DR antigen expression, lymphocyte subpopulations and proliferation-associated indices

E. Ioachim, M. Michael, C. Katsanos, A. Demou and E.V. Tsianos

Department of Pathology and Hepatogastroentrology Division Medical School, University of Ioannina, Ioannina, Greece

Offprint requests to: Dr. Elli Ioachim, Department of Pathology, Medical School, University of Ioannina, 45110 Ioannina, Greece. Fax: +30 651 46209/99212. e-mail: ioachime@otenet.gr

 

Summary. Metallothionein (MT) expression in intestinal resection specimens from 41 patients with ulcerative colitis (UC) and 10 patients with Crohn's disease (CD ) was immunohistochemically studied by the avidin-biotin (ABC) method. In addition, the possible relationship of its expression with HLA-DR antigen expression, lymphocyte subpopulations and proliferation-associated indices was studied in order to elucidate the role of this molecule in inflammatory bowel disease (IBD). The MT immunoreactivity was recorded by staining and intensity-distribution scores. MT staining varied in and was mainly localized in the cytoplasm, although a combined nuclear/cytoplasmic reactive pattern was also seen in epithelial cells. MT expression was decreased in UC, and CD compared with normal mucosa. No difference in MT expression between UC and CD was noted. In UC, a gradually decreased expression from remission, to resolving and to active phase was observed. An inverse correlation of MT expression with HLA-DR antigen expression was detected (p=0.018) in the cases of UC. The data suggest that a low level of MT expression in inflammatory bowel disease and particularly in active phase of UC may indicate a decreased endogenous intestinal protection and it may be implicated in the pathogenesis of the disease. Histol. Histopathol. 18, 75-82 (2003)

Key words: Metallothionein, HLA-DR antigen, Lymphocytes subsets, Ki-67, PCNA, Inflammatory bowel disease, Immunohistochemistry

DOI: 10.14670/HH-18.75